A Case of Infantile Cataract and Neonatal Hypoglycemia

Rym Maamouri1,2, Molka Ferchichi1,2, Amel Ben Chehida2,3

  • 1Department of Ophthalmology, Habib Thameur Hospital, Tunis, Tunisia.

PubMed

Insights

Neonatal hypoglycemia can lead to infantile cataracts in children. Meticulous history-taking is crucial for identifying at-risk children before cataract surgery.

Area of Science:

  • Ophthalmology
  • Pediatrics
  • Metabolic Disorders

Background:

  • Congenital and infantile cataracts are significant causes of visual impairment in children.
  • Neonatal hypoglycemia is a critical condition that can have long-term health implications.
  • The link between metabolic derangements and cataract formation in pediatric populations warrants further investigation.
Abstract

Related Concept Videos

Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
6.0K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
922
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
257